Purchase Order 36C77018P1083
- Not listed
- This federal contract award was made by the Department of Veterans Affairs (VA) Veterans Health Administration to Sterisyn Inc., a self-certified small disadvantaged business, for the purchase of various pharmaceutical products. The $189,057.96 firm fixed price contract was awarded on October 5, 2020 under the VA's Federal Supply Schedule (FSS) contract for pharmaceuticals and drugs, with a potential value of $360,000 through April 2024. Under this indefinite delivery vehicle, Sterisyn Inc....
- The Department of Veterans Affairs (VA) Veterans Health Administration awarded a firm fixed price purchase order to Sterisyn Inc., a self-certified small disadvantaged business, for the delivery of pharmaceuticals to VA facilities and VA Consolidated Mail Outpatient Pharmacies (CMOPs). The $499,714.80 order was placed under Sterisyn's existing Federal Supply Schedule (FSS) contract with the VA, which has a potential value of $360,000 through April 2024. This indefinite delivery vehicle allows...
- The Department of Veterans Affairs (VA) Veterans Health Administration awarded a purchase order to Sterisyn Inc., a self-certified small disadvantaged business, to provide pharmaceuticals for the VA's Consolidated Mail Outpatient Pharmacies (CMOPs). The $304,038 firm-fixed-price contract is not set aside. Sterisyn Inc. holds a multiple-award Federal Supply Schedule (FSS) contract with the VA VHA for pharmaceuticals and drugs, with a potential value of $360,000 through April 2024. This indefinite...
- The Department of Veterans Affairs Veterans Health Administration awarded a firm fixed price purchase order to Sterisyn Inc., a self-certified small disadvantaged business, for the delivery of pharmaceutical products including gabapentin, TYVASO, and naproxen. This award was issued under Sterisyn's existing Federal Supply Schedule (FSS) contract with the VA VHA, which has a potential value of $360,000 through April 2024. The specific purchase order was for a $13,050 TYVASO starter kit to be...
- This is a federal contract award to Sterisyn Inc., a self-certified small disadvantaged business, to provide pharmaceutical products to the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA). The contract award, valued at $80,136.00, is a firm fixed price purchase order for the delivery of gabapentin tablets to multiple VA Consolidated Mail Outpatient Pharmacy (CMOP) locations. This award was made under the VA VHA's Federal Supply Schedule (FSS) contract with...
- The Department of Veterans Affairs (VA) Veterans Health Administration awarded a firm fixed price purchase order contract to Sterisyn Inc., a self-certified small disadvantaged business, to provide Atrovastatin pharmaceutical products to multiple VA Consolidated Mail Outpatient Pharmacies (CMOPs). The contract has a potential value of $170,202.00 and a completion date of May 8, 2018. Sterisyn Inc. holds a multiple-award Federal Supply Schedule (FSS) contract with the VA VHA for...
- This is a firm fixed price purchase order for atorvastatin 80mg 500-count bottles awarded to Sterisyn Inc. by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) Veterans Integrated Service Network 9. The $273,600 contract has a completion date of July 30, 2018 and was awarded on July 16, 2018 without any small business set-aside designation. Sterisyn Inc. is a self-certified small disadvantaged business that provides generic pharmaceuticals to support VA healthcare...
- The Department of Veterans Affairs (VA) Veterans Health Administration (VHA) awarded a firm fixed price purchase order to Sterisyn Inc., a small disadvantaged business, to provide 18,964 units of Atorvastatin CA 80MG tablets for the VA's Consolidated Mail Outpatient Pharmacies (CMOPs). The order, valued at $720,632.00, is to be completed by February 12, 2018. Sterisyn Inc. has an existing Federal Supply Schedule (FSS) contract with the VA VHA for pharmaceuticals and drugs, which allows the...
- This is a federal delivery order contract awarded by the U.S. Department of Veterans Affairs (VA) to Steris Corporation, a global provider of infection prevention and medical equipment services. The $530,208.71 firm-fixed-price contract was awarded on December 1, 2020, and has an ultimate completion date of November 30, 2025. The contract was not set aside and was awarded under the VA's Medical Equipment and Supplies (FSS-65-II-A) Federal Supply Schedule. The contract provides for STERIS service...
- The Department of Veterans Affairs awarded a firm fixed price purchase order contract to United Drug Supply Inc., a woman-owned small business, for the delivery of pharmaceuticals to multiple VA medical facilities. The contract has a total potential value of $211,068.00 and was set aside for small businesses. United Drug Supply is a pharmaceutical and medical supply distributor that serves military and VA facilities, and has held previous VA Federal Supply Schedule contracts for medical products...
The Department of Veterans Affairs (VA) Veterans Health Administration awarded a firm fixed-price purchase order to Sterisyn Inc., a self-certified small disadvantaged business, for $142,905.00 to provide pharmaceutical products to support VA healthcare programs for veterans. This order was placed under Sterisyn's existing Federal Supply Schedule (FSS) contract with the VA, which has a potential value of $360,000 through April 2024 and allows the company to provide pharmaceuticals, drugs, and hematology-related products nationwide. The contract is not set aside for any specific business designation. Under this FSS contract, Sterisyn has previously provided gabapentin tablets, naproxen tablets, and other drugs to VA facilities and VA Consolidated Mail Outpatient Pharmacies (CMOPs) across various regions.
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
Gabapentin | 36C77018Q0419 | Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 15 | Award Notice 1/1 | 4/10/18, 1:29 PM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $142.9k | 4/17/18 |